Diabetes mellitus (DM) is a disease caused by lacking of insulin production or by the inability of cells to respond to insulin (insulin resistance). According to the International Diabetes Federation, diabetes cases in the world reach 425 millions and are predicted to increase to 625 millions by 2045. The trend of increasing cases and death rates due to diabetes needs a special attention, especially in the pattern of it’s treatment. Diabetes treatment using natural ingredients is one of the most researched fields in the world because it is effective and safe. Curculigo latifolia Dryand. ex W.T. Aiton and Curculigo orchioides Gaertn. belonging to the family Hypoxidaceae, annual herbs with lanceolate-shaped leaves or parallel lanceolate arranged in a rosette, with yellow flowers, very short stems, and have a long cylindrical rhizome. A total of 39 species of this genus are accepted in the World Checklist of Selected Plant Families (WCSP 2020), including these two species. Both species are known as traditional medicinal plants in various tropical regions. Rhizome of Curculigo spp. is one of the raw material sources for traditional medicine to treat DM; this pharmacological effect comes from secondary metabolites. Those compounds are distributed and accumulated in certain secretory structures within the plant. However, the activities of the active compounds in such diverse plant organs are very difficult to be determined in a short time, as well as its pharmacokinetic and pharmacodynamics parameters. In addition, compounds produced under normal conditions in the nature are very low. Therefore, this study aimed to determine the distribution of secretory structures and the producing and/or accumulating sites of the bioactive compounds through histochemical tests, to determine which bioactive compounds contribute the most to diabetes mellitus, especially in antioxidant activity and α-glucosidase inhibition, and to determine their pharmacokinetics and pharmacodynamics parameters. In addition, this research was also carried out to produce callus and micropropagate the plants, as well as to ensure the existence of those bioactive compounds in in vitro cultured callus. Determination of secretory structure using cross sections of fresh samples according to plant anatomical procedures and histochemical analysis using several reagents were performed to detect groups of metabolites. Determination of bioactive compounds was done using an analysis combination on biological activities (antioxidants and α-glucosidase inhibition) with metabolite fingerprint using FTIR and metabolite profiling with UHPLC-Q-Orbitrap HRMS-based metabolomic and chemometric techniques using partial least squares regression analysis (PLSR). Pharmacokinetics and pharmacodynamics parameters were determined using Lipinski's rule of five, pharmacological networks using Cytoscape, and molecular docking with PyRx, PyMOL, and BIOVIA Discovery Studio. Callus production and micropropagation began with explant sterilization using environmental-friendly sterilants. Callus initiation and organogenesis were induced by various concentrations of auxins and cytokinin. Metabolomic analysis based on metabolite profiling using UHPLC-Q-Orbitrap HRMS and chemometric techniques using principal component analysis (PCA) were carried out to identify the compounds in the callus and plantlet’s leaves. The anatomical and histochemical analysis of fresh tissues showed that all organs contained secretory structures that accumulated various metabolites. The secretory structures identified in the roots, rhizomes, petiole, and leaves of these two species were secretory cavities and idioblasts. The group of compounds identified were phenols, alkaloids, terpenes, essential oils, and lipophilic. They were also spread over some common tissues of the organs. Based on metabolomic and chemometric analysis the main compounds contributing in antioxidant and α-glucosidase inhibition activities were notified from the phenol group, such as curculigoside B, orchioside B; 2,4-Dichloro-5-methoxy-3-methylphenol, orcinol glucoside; 1,1-Bis-(3,4-dihydroxyphenyl)-1-(2-furan)-methane; from the terpene group, such as: curculigosaponin G, H, and I; from the norlignan group, (1S,2R)-O-Methylnyacoside; and from the aldehyde group, 5-hydroxymethylfural, while the functional groups included O–H, C=O, C–O, C–H. These compounds were accumulated more abundantly in the leaves of C. latifolia (DLSP) from Sinjai-Palangka and C. orchioides (DOGM) from Gowa-Malakaji. Pharmacokinetic parameters showed that 33 out of the 79 compounds were able to be absorbed properly, while some compounds did not meet the requirements. The latter compounds must be converted into aglycones if they will be used as medicinal substances. The cynanuriculoside ligand A_qt based on pharmacological network analysis and molecular docking was able to interact pharmacodynamically with hydroxysteroid (11-beta) dehydrogenase 1 (HSD11B1) target via 6NJ7 receptor, resulting an affinity of –12.0 (kcal mol–1), with amino acid residues in the form of Ala 226, Leu 126, Val 180, Tyr 183, Leu 215, Ser 170, Ile 121, and Val 168. The sterilization of explants with the lowest concentrations of sterilizing agents and a short contact time with the explants produced 90% sterile cultures. The best combination of plant growth regulators (PGRs) for callus induction in C. latifolia and C. orchioides were BAP : IBA at 3 : 5 and 5 : 3 mg L–1, respectively. The callus were green and white, with a compact consistency. Those combinations of PGRs also regenerated shoots and roots in both species. The secretory structures found in the callus were secretory cavities and idioblast cells. In the callus of C. latifolia, phenol was identified in the organogenic parts and epithelium cells of the secretory cavities, and the essential oils were in idioblast cells; while C. orchioides’ callus contained phenol in the organogenic parts only. The compounds that had contribution in antioxidant and α-glucosidase inhibition activities, such as 1,1-Bis-(3,4-dihydroxyphenyl)-1-(2-furan)-methane, (1S,2R)-O-Methylnyacoside; 2,4-Dichloro-5-methoxy-3-methylphenol, curculigoside B, curculigosaponin G, H, and I; orchioside B, and orcinol glucoside were also identified in the callus and plantlet’s leaves. Most of them belong to the phenol group. The general conclusion of this study is that histochemical techniques revealed that there were differences in the accumulation sites of compounds among organs of Curculigo spp. Histochemically, phenolic compounds were identified in the rhizome, petiole, and leaves of C. latifolia, while in C. orchioides they were only identified in the rhizome. Phenolics were also found in the organogenic callus of these two species. From the metabolomic-chemometric analysis, compounds that contributed greatly to the antioxidant and α-glucosidase inhibition activities were accumulated in the leaves of both species. From the pharmacological network and molecular docking approaches, cynanuriculoside A_qt, curculigosaponin L_qt, and curculigenin B were confirmed to have potential for the treatment of diabetes mellitus. The compounds found in the plant’s organs of C. latifolia and C. orchioides that contribute greatly in antioxidant and α-glucosidase inhibition activities were also identified in the callus and plantlet’s leaves resulted from in vitro cultures. Some of which even demonstrated higher concentration (peak area) than those of the original plant organs.